Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Part of the Mycota brand family (generic: Undecenoic acid + Dichlorophen)
MHRA licensed products
View all licensed products for Undecenoic acid + Dichlorophen on the MHRA register
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 2 · 1998–2025
Showing the 50 most relevant studies, sorted by most relevant.
Susana Fernandes, Anabela Borges, Inês B. Gomes, et al.
Food Research International, 2023
Shengyu Dai, Changle Chen
Macromolecules, 2018
V. Rahman, Sayeed Mukhtar, W. H. Ansari, et al.
European journal of medicinal chemistry, 2005
Hua Wei, Xianzheng Zhang, Han Cheng, et al.
Journal of controlled release : official journal of the Controlled Release Society, 2006
Suman Rana, Suman Rana, Neena G. Shetake, et al.
Dalton transactions, 2016
A. M. Api, D. Belsito, D. Botelho, et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018
K. Padmaja, B. Rao, R. K. Reddy, et al.
Industrial Crops and Products, 2012
Huanhuan Shi, Jianbiao Peng, Jianhua Li, et al.
Journal of hazardous materials, 2016
Hiroki Takeshita, Akito Nishiyama, Xiuxiu Wang, et al.
Biomacromolecules, 2025
Biobased polyesters, recyclable sustainable polymers derived from renewable feedstock, are promising alternatives to petroleum-based polymers. The crystallization behavior, crystal structure, and supramolecular structures of a series of biobased long-chain aliphatic polyesters, consisting of a diester of 10-undecenoic acid with isosorbide (IS), isomannide (IM), and butanediol (BD) as the midsegments, were studied by various scattering methods and Raman spectroscopy. Polyesters containing butanediol-type midsegments (C18BD) participated in the crystallization by being incorporated into the orthorhombic polyethylene crystal lamellae. The polyesters containing isosorbide- and isomannide-type midsegments (C18IS, C18IM) were excluded from the crystal lamellae and inhibited the formation of orthorhombic crystals; the lamellar thickness was thus determined by the length of the methylene chains between the midsegments. An introduction of these midsegments (IS, IM) led to formation of some loose structures even in the molten state; acceleration of the nucleation led to a heterogeneous nucleation-like crystallization behavior, and the final spherulite size was finer.
Abstract licence: CC BY-NC-ND
C.A. Ospina-Delacruz, V. Castillo-Gallardo, D. Ariza-Flores, et al.
Materials Letters, 2023
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.